THE SERUM LEVELS OF SE-SELECTIN ARE INCREASED IN PATIENTS WITH BULLOUS PEMPHIGOID OR PEMPHIGUS-VULGARIS - CORRELATION WITH THE NUMBER OF SKIN-LESIONS AND RECOVERY AFTER CORTICOSTEROID-THERAPY
L. Dauria et al., THE SERUM LEVELS OF SE-SELECTIN ARE INCREASED IN PATIENTS WITH BULLOUS PEMPHIGOID OR PEMPHIGUS-VULGARIS - CORRELATION WITH THE NUMBER OF SKIN-LESIONS AND RECOVERY AFTER CORTICOSTEROID-THERAPY, British journal of dermatology, 137(1), 1997, pp. 59-64
Soluble E (sE)-selectin represents the soluble isoform of cellular E-s
electin, an adhesion molecule synthesized only by endothelial cells. A
s a consequence, it may be considered a marker of endothelial activity
. The aim of this study was therefore to evaluate the serum levels of
sE-selectin in nine patients affected with pemphigus vulgaris (PV) and
in 15 patients with bullous pemphigoid (BP). Higher amounts of sE-sel
ectin, median 40.3 ng/mL, range 30-109.6 were found in the patients wh
en compared with 20 healthy individuals, median 28.5 ng/mL, range 6.4-
48; P < 0.01, matched for sex and age, These levels were also signific
antly correlated with the number of detectable lesions (r = 0.63, P <
0.001) when the patient data were considered at the time of the first
observation, Thirteen subjects were followed over time for a maximum o
f 3 months (from three to seven observations). During therapy, the num
ber of lesions and the serum sE-selectin values decreased concomitantl
y, Differently from sE-selectin, the serum soluble intercellular adhes
ion molecule-1 (sICAM-1) values were not significantly different in th
e patients from the controls and showed no correlation with the serum
sE-selectin concentrations or with the number of lesions. The data pre
sented point to the possible use of sE-selectin determinations as a no
n-specific follow-up marker, suitable to gauge disease intensity over
time and emphasize that endothelial activation is present in BP as wel
l as in PV.